fibro-inflammatory diseases

Huge €410M Licensing Deal for Fibro-Inflammatory Disease Treatments

📣 Boehringer Ingelheim partners with Kyowa Kirin Co., Ltd. for €410m license deal to treat fibro-inflammatory diseases! 🧪💰